85 completed, 19 terminated, 11 recruiting, 7 unknown. 62 Phase 1, 25 Phase 2, 22 Not applicable, 8 Phase 3, 2 Phase 4.
Follow Neoplasm: new trials by email Literature Review of Neoplasm trials Research Report on Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial Artificial Intelligence-Assisted Fluid Management, Standard fluid management - Neoplasm, Cancer | Not applicable | Not yet recruiting | National Cancer Institute, Naples | 176 | 2026-12-01 | 2026-11-12 |
| REstoring Metabolic FLEXibility Through Combined Exercise in Breast Cancer Survivors: A Randomized Controlled Trial. Control, Exercise - Cancer, Breast Cancer | Not applicable | Not yet recruiting | University of Castilla-La Mancha | 44 | 2026-09-01 | 2026-05-28 |
| Digital Psychoeducational Intervention for Young Adults With Fertility Related Distress Following Cancer Diagnosis Digital psychoeducational intervention, control group (standard of care + placebo). - Neoplasm, Cancer | Not applicable | Not yet recruiting | Gadjah Mada University | 38 | 2026-08-24 | 2026-07-27 |
| Association Between 4D MRI Parameters and the Clinical Characteristics and Prognosis of Major Chronic Diseases Cardiovascular Disease, Cardiac Magnetic Resonance Imaging | Recruiting | Ulsan University Hospital | 1000 | 2026-07-01 | 2026-09-23 | |
| Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming for Advanced Solid Tumors Mechanobiologically Reprogrammed Macrophage-Derived Exosomes (1×10^10 exosomes), Mechanobiologically Reprogrammed Macrophage-Derived Exosomes (2.5×10^10 exosomes), Mechanobiologically Reprogrammed Macrophage-Derived Exosomes (5×10^10 exosomes) - Advanced Solid Tumors, Neoplasm | Phase 1 | Recruiting | West China Hospital | 9 | 2026-05-10 | 2026-05-11 |
| EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study EMDR-IGTP-OTS - Thyroid Neoplasms, Neoplasm | Not applicable | Recruiting | Università Cattolica di Milano | 25 | 2025-12-05 | 2026-03-04 |
| Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib [14C] AZD6738, AZD6738 / ceralasertib - Neoplasm | Phase 1 | Terminated | AstraZeneca | 2 | 2025-09-22 | 2026-09-03 |
| A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma KLN-1010 - Multiple Myeloma in Relapse, Myeloma Multiple | Phase 1 | Recruiting | Kelonia Therapeutics, Inc. | 70 | 2025-07-16 | 2026-08-28 |
| Preoperative Radiation Therapy and Immediate Breast Reconstruction Preoperative radiotherapy, Postoperative radiotherapy, Immediate breast reconstruction - Breast Neoplasms, Breast Carcinoma | Not applicable | Recruiting | Cancer Research Antwerp | 180 | 2025-02-20 | 2026-02-04 |
| Dream2Heal: An Adaptive Stepped-care Intervention for Chinese Cancer Survivors With Mild-to-moderate Insomnia iDream2Heal, Easy Exercise, Dream2Heal - Neoplasm, Sleep Disturbance | Not applicable | Recruiting | The University of Hong Kong | 72 | 2025-02-01 | 2026-08-13 |
| A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies COM503, Zimberelimab - Neoplasm, Cancer, Malignant Tumors | Phase 1 | Recruiting | Compugen Ltd | 200 | 2025-01-07 | 2026-08-12 |
| Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology. Pharmaceutical consultation, Pharmaceutical consultation and follow-up - Neoplasm | Not applicable | Active not recruiting | Polyclinique Lyon Nord | 90 | 2024-12-31 | 2026-10-05 |
| Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT) Creation of a laboratory network, Mapping of genomic alterations, Creation of a bioinformatics network among the participating institutions. - Neoplasm | Recruiting | National Cancer Institute, Naples | 16000 | 2024-12-10 | 2025-03-25 | |
| Cancer in the Small Developing Island States of the Eastern Caribbean Overeseas travel for care - Neoplasm | Enrolling by invitation | Vaughan A. Lewis Institute for Research and Innovation | 900 | 2024-09-16 | 2026-07-10 | |
| CARE Study: Cancer, Asian Americans, and Relationship Enrichment Contribution to Caregivers Well-Being, Control - Neoplasm | Not applicable | Recruiting | Fox Chase Cancer Center | 186 | 2024-08-06 | 2025-12-31 |
| A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients Sham VR, Active VR - Neoplasm, Caregivers | Not applicable | Completed | National Institutes of Health Clinical Center (CC) | 28 | 2024-06-05 | 2026-04-20 |
| Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention) MiLES - Cancer, Neoplasm | Phase 2 / Phase 3 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 140 | 2023-12-18 | 2024-11-04 |
| Body Composition and Inflammatory-Metabolic Indices in Immunotherapy-Treated Metastatic Non-Small Cell Lung Cancer: The SARC-CTI Study Immune Checkpoint Inhibitor-Based Therapy - Metastatic Non-small Cell Lung Cancer, Neoplasm | Completed | Ankara Etlik City Hospital | 155 | 2022-12-01 | 2026-10-05 | |
| Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors Tusamitamab ravtansine - Neoplasm | Phase 1 | Terminated | Sanofi | 56 | 2022-10-03 | 2025-04-06 |
| Retrospective WGS Study No intervention - Cancer, Pediatric Cancer | Enrolling by invitation | The Wellcome Sanger Institute | 2000 | 2022-09-22 | 2025-02-11 |
Showing 20 of 134. Sign in to see all of them.
Neoplasms (134) · Neoplasm Metastasis (18) · Breast Neoplasms (6) · Lymphoma (6) · Melanoma (5) · Carcinoma, Non-Small-Cell Lung (4) · Anemia (3) · Colorectal Neoplasms (3) · Esophageal Neoplasms (3) · Multiple Myeloma (3) · Pain (3) · Pancreatic Neoplasms (3) · Prostatic Neoplasms (3) · Brain Neoplasms (2) · Carcinoma, Hepatocellular (2)
Neoplasms by Site (31) · Pathological Conditions, Signs and Symptoms (31) · Pathologic Processes (26) · Neoplasms by Histologic Type (21) · Neoplastic Processes (18) · Digestive System Diseases (14) · Hemic and Lymphatic Diseases (14) · Skin and Connective Tissue Diseases (14) · Skin Diseases (13) · Digestive System Neoplasms (12) · Immune System Diseases (11) · Gastrointestinal Diseases (9) · Lymphatic Diseases (9) · Lymphoproliferative Disorders (9) · Gastrointestinal Neoplasms (8)
atezolizumab (4) · pembrolizumab (4) · Bevacizumab (3) · Epoetin Alfa (3) · Nivolumab (3) · Radiotherapy (3) · erdafitinib (3) · BCT-100 (2) · Cetuximab (2) · Control Groups (2) · Crizotinib (2) · Doxorubicin (2) · Ipilimumab (2) · P276-00 (2) · Pemetrexed (2)
National Cancer Institute (NCI) (19) · Eli Lilly and Company (6) · Sanofi (5) · Merck Sharp & Dohme LLC (4) · Atridia Pty Ltd. (3) · Bayer (3) · National Institutes of Health Clinical Center (CC) (3) · Pfizer (3) · SynerGene Therapeutics, Inc. (3) · Asana BioSciences (2) · Assistance Publique - Hôpitaux de Paris (2) · AstraZeneca (2) · Bio-Cancer Treatment International Limited (2) · Boehringer Ingelheim (2) · Columbia University (2)
United States (76) · Canada (11) · France (8) · Spain (7) · United Kingdom (7) · Belgium (6) · China (6) · Italy (6) · South Korea (6) · Germany (5) · Japan (5) · Australia (4) · Netherlands (4) · Taiwan (4) · Brazil (3)
Raghunadharao D, MD, DM (2) · Ronnie TP Poon, Prof (2) · Alfred-Marc Iloreta, MD (1) · Alice P Chen, M.D. (1) · Andreas Arnold, MD (1) · Anna Pavlick, DO (1) · Antonella De Luca (1) · Arlene Siefker-Radtke, M.D. (1)
PMID 15953714, PMID 19139966, PMID 19238148, PMID 19728336, PMID 20077050, PMID 20955619, PMID 21724150, PMID 21978930, PMID 22143378, PMID 22570147, PMID 22864522, PMID 22894607, PMID 23054206, PMID 24919854, PMID 26210348, PMID 27461586, PMID 27565426, PMID 28981596, PMID 31256014, PMID 31401903, PMID 32554315, PMID 33845905, PMID 33856599, PMID 34172290, PMID 34627853, PMID 35086719, PMID 35598186, PMID 36096532, PMID 36335217, PMID 36813886, PMID 36870947, PMID 37219686, PMID 37424386, PMID 38516258, PMID 38630551, PMID 38935102, PMID 39138436, PMID 39403043, PMID 39868569, PMID 40110060, PMID 41102780, PMID 41408891, PMID 41798120, PMID 41986720, PMID 42046025, PMID 42536966, PMID 42547239, PMID 42705861, PMID 42830556
2023 (2), 2008 (1), 2017 (1), 2018 (1), R00CA267678 (1), UL1RR024156 (1)